SCHEMBL6247381

SCHEMBL6247381

CC(C)(C)OC(=O)Nc1sc2c(c1C#N)CCCC2

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.70
▸ RAB9A P51151 5/20 0.70
▸ NPC1 O15118 4/20 0.70
▸ GAA P10253 2/20 0.67
▸ MEN1 O00255 1/20 0.67
▸ KMT2A Q03164 1/20 0.67
▸ L3MBTL1 Q9Y468 2/20 0.67
▸ POLB P06746 2/20 0.67
▸ HTT P42858 2/20 0.66
▸ SMN1; SMN2 Q16637 3/20 0.62
▸ USP2 O75604 1/20 0.61
▸ MAPK1 P28482 1/20 0.61
▸ ATM Q13315 1/20 0.61
▸ MAPT P10636 2/20 0.61
▸ BACE1 P56817 1/20 0.59
▸ PKM P14618 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3277999 0.83 L3MBTL1 (0.95) ALDH1A1RAB9ANPC1GAAMEN1
SCHEMBL24858528 0.81 POLB (0.50) ALDH1A1RAB9ANPC1GAAMEN1
SCHEMBL3277689 0.81 GAA (1.00) ALDH1A1RAB9ANPC1GAAMEN1
SCHEMBL13631324 0.79 ALDH1A1 (0.56) ALDH1A1GAAMEN1KMT2ASMN1; SMN2
SCHEMBL12057595 0.79 PTPN1 (0.62) ALDH1A1RAB9ANPC1GAAMEN1
SCHEMBL11924459 0.79 MEN1 (0.70) ALDH1A1RAB9ANPC1GAAMEN1
SCHEMBL12057606 0.78 PTPN1 (0.63) ALDH1A1RAB9ANPC1GAAMEN1
SCHEMBL6246277 0.78 ALDH1A1 (0.74) ALDH1A1RAB9ANPC1GAAMEN1
SCHEMBL3914257 0.77 BACE1 (0.79) ALDH1A1RAB9ANPC1GAAMEN1
SCHEMBL11377314 0.77 L3MBTL1 (0.71) ALDH1A1RAB9ANPC1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665719-A1 SMALL MOLECULE TREATMENT OF FATTY LIVER DISEASE AND HCC ScandiEdge Therapeutics AB (SE) 2025-12-24 — — EP disclosed
WO-2024170693-A1 SMALL MOLECULE TREATMENT OF FATTY LIVER DISEASE AND HCC SCANDIEDGE THERAPEUTICS AB (SE) 2024-08-22 — — WO disclosed
WO-2005044008-A2 2 -AMINOTHIOPHENE COMPOUNDS AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2005-05-19 — — WO disclosed
Send feedback